CAMDEN 2020

Camden and Islington NHS Foundation Trust

	Response
ECT
1. Please supply patient’s information ECT leaflet.	See attached our leaflet and CQC leaflet
2. Please supply patient ECT consent form.	See attached consent form and outpatient agreement
3. Please supply any ECT reports/investigations	None
4. How many ECT in 2020?	179 treatments
5. What proportion of patients were men/women?	13 women and 6 men
6. How old were they?	S12
7. What proportion of patients were classified BAME?	S12
8. How many were receiving ECT for the first time?	S12
9. How many patients consented to ECT?	5 women and 1 man were able to give informed consent to ECT.
10. How many ECT complaints were investigated outside the NHS and CCG?	10) We had no ECT complaints
11. How many patients died during or 1 month after ECT and what was the cause (whether or not ECT was considered the cause)?	None
12. How many patients died within 6 months after ECT and what was the cause (whether or not ECT was considered the cause)?	None
13. How many patients died by suicide within 6 months of receiving ECT (whether or not ECT was considered the cause)?	None
14. How many patients have suffered complications during and after ECT and what were those complications?	None
15. Have there been any formal complaints from patients/relatives about ECT?	None
16. If so, what was their concerns?	N/A
17. How many patients report memory loss/loss of cognitive function?	Almost all patients experience short term memory loss around ECT, evidence shows this does not persist beyond 3 months following the end of ECT. No patient complained of memory loss persisting past this period.
18. What tests are used to assess memory loss/loss of cognitive function?	Mini Mental State Examination is our standard test however many of our patients have additional tests such as the ACE3.
19. Have MRI or CT scans been used before and after ECT?	ECT / MRI scans are not a requirement for ECT although a number of our patients will have had them as part of the investigation of their illness prior to being prescribed ECT.
20. If so what was the conclusion?	N/A
21. How does the Trust plan to prevent ECT in the future?	ECT is a safe and effective treatment for life-threatening-depression and treatment-resistant-depression. We see patients recover function, we see them get better, we see them improve and get their lives back. ECT is not for everyone but for those it helps it can be a life-saver. We will continue to offer ECT judiciously and carefully for those for whom it is indicated.

Please provide SERIOUS INCIDENT information under the FOI act to the following questions: -
1. Please supply any serious incident reports/investigations	Section 40 Personal Information
2. How many SERIOUS INCIDENT REPORTS in 2020?	26
3. What proportion of patients were men/women?	74% men, 26% women (17/7)
4. How old were they?	Age range 20 to 66
5. What proportion of patients were classified BAME?	15%
6. How many SERIOUS INCIDENT REPORTS were investigated outside the NHS and CCG?	0
7. How many patients died during or 1 month after SERIOUS INCIDENT REPORTS and what was the cause (whether or not SERIOUS INCIDENT REPORTS was considered the cause)?	0
8. How many patients died within 6 months after SERIOUS INCIDENT REPORTS and what was the cause (whether or not SERIOUS INCIDENT REPORTS was considered the cause)?	0
9. How many patients died by suicide within 6 months of receiving SERIOUS INCIDENT REPORTS (whether or not SERIOUS INCIDENT REPORTS was considered the cause)?	0
10. How many patients have suffered complications during and after SERIOUS INCIDENT REPORTS and what were those complications?	S12
11. Have there been any formal complaints from patients/relatives about SERIOUS INCIDENT REPORTS?	Yes - 2
12. If so, what was their concerns?	Themes, Inpatient care provided to service user and assessment and management of risk; Rigour of assessment when service user presented at hospital and assessed by C&I and rationale for decisions made.
13. How does the Trust plan to prevent SERIOUS INCIDENTS in the future?	All serious incidents in the Trust are subject to a review of the care that was delivered to identify any potential gaps in care or service delivery. Where potential gaps are identified, a more in-depth investigation is undertaken to identify areas for learning and quality improvement actions. Lessons are shared to promote proactive actions to prevent occurrence where relevant

Please provide restraints information under the FOI act to the following questions: -
1. Please supply any Restraints/investigations	We are not obliged to retrieve this information as S12 applies
2. How many RESTRAINTS in 2020?	We are not obliged to retrieve this information as S12 applies
3. What proportion of patients were men/women?	We are not obliged to retrieve this information as S12 applies
4. How old were they?	We are not obliged to retrieve this information as S12 applies
5. What proportion of patients were classified BAME?	We are not obliged to retrieve this information as S12 applies
6. How many RESTRAINTS were investigated outside the NHS and CCG?	We are not obliged to retrieve this information as S12 applies
7. How many patients died during or 1 month after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?	We are not obliged to retrieve this information as S12 applies
8. How many patients died within 6 months after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?	We are not obliged to retrieve this information as S12 applies
9. How many patients died by suicide within 6 months of receiving RESTRAINTS (whether or not RESTRAINTS was considered the cause)?	We are not obliged to retrieve this information as S12 applies
10. How many patients have suffered complications during and after RESTRAINTS and what were those complications?	We are not obliged to retrieve this information as S12 applies
11. Have there been any formal complaints from patients/relatives about RESTRAINTS?	We are not obliged to retrieve this information as S12 applies
12. If so, what was their concerns?	We are not obliged to retrieve this information as S12 applies
13. Are counts of forced injections available?	We are not obliged to retrieve this information as S12 applies
14. How does the Trust plan to reduce restraints in the future?	We are not obliged to retrieve this information as S12 applies

Please provide SECLUSION information under the FOI act to the following questions: -
1. Please supply any SECLUSION reports/investigations	We are not obliged to retrieve this information as S12 applies
2. How many SECLUSIONS in 2020?	We are not obliged to retrieve this information as S12 applies
3. What proportion of patients were men/women?	We are not obliged to retrieve this information as S12 applies
4. How old were they?	We are not obliged to retrieve this information as S12 applies
5. What proportion of patients were classified BAME?	We are not obliged to retrieve this information as S12 applies
6. How many SECLUSIONS were investigated outside the NHS and CCG?	We are not obliged to retrieve this information as S12 applies
7. How many patients died during or 1 month after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?	We are not obliged to retrieve this information as S12 applies
8. How many patients died within 6 months after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?	We are not obliged to retrieve this information as S12 applies
9. How many patients died by suicide within 6 months of receiving SECLUSION (whether or not SECLUSION was considered the cause)?	We are not obliged to retrieve this information as S12 applies
10. How many patients have suffered complications during and after SECLUSION and what were those complications?	We are not obliged to retrieve this information as S12 applies
11. Have there been any formal complaints from patients/relatives about SECLUSION?	We are not obliged to retrieve this information as S12 applies
12. If so, what was their concerns?	We are not obliged to retrieve this information as S12 applies
13. How does the Trust plan to prevent SECLUSION in the future?	We are not obliged to retrieve this information as S12 applies

Please provide MEDICATION ERRORS information under the FOI act to the following questions: -
1. Please supply any MEDICATION ERRORS reports/investigations	Section 40 Personal Information
2. How many MEDICATION ERRORS in 2020?	319
3. What proportion of patients were men/women?	133 women and 128 men
4. How old were they?	Age band Count 0-20 4 21-30 8 31-40 24 41-50 34 51-60 44 61-70 53 71-80 58 80+ 5 The remainder of incidents either did not directly involve patients or the patient details were not recorded.
5. What proportion of patients were classified BAME?	See medication error tab.
6. How many MEDICATION ERRORS were investigated outside the NHS and CCG?	N/A. We would only investigate errors involving our trust practice therefore only NHS.
7. How many patients died during or 1 month after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?	S12
8. How many patients died within 6 months after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?	S12
9. How many patients died by suicide within 6 months of receiving MEDICATION ERRORS (whether or not MEDICATION ERRORS was considered the cause)?	S12
10. How many patients have suffered complications during and after MEDICATION ERRORS and what were those complications?	S12
11. Have there been any formal complaints from patients/relatives about MEDICATION ERRORS?	S12
12. If so, what was their concerns?	S12
13. How does the Trust plan to prevent MEDICATION ERRORS in the future	Improving medicines safety is one of the key priorities for the trust. The trust has got a medicines safety officer in post who chairs the Medicines Safety Group. The Medicines Safety Group provides a framework to enable safe use of medicines. The aims of the Group are to change the culture around incident reporting, identify the common themes of medicine incidents and take the learning forward to change practice. The Group reviews all the medicines incidents and produces thematic review each month. It also provides regular monthly feedback on medication incidents to the teams with the examples of incidents and learning lessons. The medication safety officer works closely with quality and patient safety teams to review quality and risk management issues related to medicines use. They also work in collaboration with the wards and teams around the trust to build a culture of medicines safety and implement changes to prevent similar future incidents.

MEDICATION ERRORS MORE INFORMATION - What proportion of patients were classified BAME?
Bangladeshi	9
Black African	32
Black Carribean	19
Chinese	<5
Indian	<5
Mixed white and Asian	<5
Mixed white and black African	<5
Mixed white and black Carribean	<5
Not stated	13
Other Asian	9
Other Black	8
Other ethnic category	8
Other mixed	<5
Pakistani	<5
White - British	93
White - Irish	7
White - other white	35
Total	253

**The remainder of incidents either did not directly involve patients or the patient details were not recorded**

Where data is 5 or below, we have answered with a default <5 by virtue of section 40.
Section 40(2) Personal Information Information disclosed under FOI is effectively released to the wider world or into the public domain. Consequently, in cases where the public request information related to individuals, it would be very rare for the Trust to release such information under the terms of the FOI Act. Individuals would not expect that personal data would be disclosed in response to a request under the FOI Act that could provide and identify an individual or family members related to the subject matter, any disclosure would breach the first data protection principle of the Data Protection Act, GDPR, which relates to fair processing, Article 5(1) requires that personal data shall be: (a) processed lawfully, fairly and in a transparent manner in relation to individuals (‘lawfulness, fairness and transparency’)